Cleared Traditional

K222115 - ISAAC Neurovascular Navigation Catheter

K222115 is the FDA 510(k) clearance for ISAAC Neurovascular Navigation Catheter by MicroVention, Inc.. It is a Class 2 Neurology device (product code DQY) cleared through the Traditional 510(k) pathway after a 176-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2023
Decision
176d
Days
Class 2
Risk

K222115 is an FDA 510(k) clearance for the ISAAC Neurovascular Navigation Catheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by MicroVention, Inc. (Aliso Viejo, US). The FDA issued a Cleared decision on January 10, 2023 after a review of 176 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 870.1250 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all MicroVention, Inc. devices

Submission Details

510(k) Number K222115 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 18, 2022
Decision Date January 10, 2023
Days to Decision 176 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d slower than avg
Panel avg: 148d · This submission: 176d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K222115.
RayFlow
K222023 · Hexacath · Apr 2023
CPS Locator 3D Delivery Catheter
K230363 · CenterPoint Systems, LLC · Mar 2023
6F Wallaby Long Sheath
K222603 · Wallaby Medical, Inc. · Mar 2023
SelectSite C304 Deflectable Catheter System, C315 Delivery System
K223178 · Medtronic · Nov 2022
Attain Command + SureValve Delivery System, Attain Select II + SureValve delivery system
K222873 · Medtronic · Nov 2022
Houdini Cross Support Catheter
K213466 · Cruzar Medsystems, Inc. · Oct 2022